Maximum quantity allowed is 999
请选择数量
CAS RN: 42864-78-8 | 產品號碼: B5372
Bevantolol Hydrochloride
包裝 | 價格 | 同一天 | 2-3个工作日 |
---|---|---|---|
250MG |
NT$6,200
|
2 | 聯繫我們 |
1G |
NT$16,680
|
2 | 1 |
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準,敬請留意。
產品號碼 | B5372 |
純度/分析方法 | >98.0%(HPLC) |
分子式 / 分子量 | C__2__0H__2__7NO__4·HCl = 381.90 |
外觀與形狀(20°C) | Solid |
儲存條件 | Room Temperature (Recommended in a cool and dark place, <15°C) |
包裝和容器 | 250MG-Glass Bottle with Plastic Insert (閲覽圖片) |
CAS RN | 42864-78-8 |
相關CAS RN | 59170-23-9 |
Reaxys-RN | 5195067 |
PubChem Substance ID | 354334983 |
Merck Index(14) | 1192 |
MDL編號 | MFCD00941389 |
產品規格
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(with Total Nitrogen) | min. 97.0 % |
Melting point | 139.0 to 144.0 °C |
性質
熔點 | 142 °C |
溶解性(可溶於) | Chloroform |
溶解性(不溶於) | Ether |
GHS
圖形表示 | |
信號詞 | Warning |
危險性說明 | H302 : Harmful if swallowed. |
防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
相關法規
運輸資料
HS編碼* | 2922.50-000 |
Application
Bevantolol Hydrochloride: A β1-Adrenoceptor Antagonist with an Affinity to α1-Adrenoceptors
Bevantolol hydrochloride (NC-1400) is a β1-adrenoceptor antagonist with a relatively high affinity to α1-adrenoceptor subtypes, and also acts as calcium channel antagonist. Bevantolol has a peripheral vasodilatory effect, and is used for the treatment of angina and hypertension. In addition, bevantolol hydrochloride is a racemic mixture, and methods have been developed for the enantioselective separation. (The product is for research purpose only.)
References
- (±)-1-[[2-(3,4-Dimethoxphenyl)ethyl]amino]-3-(3-methylphenoxy)-2-propanol hydrochloride (bevantolol, NC-1400) as a β1-selective adrenoceptor blocker with α1-adrenoceptor blocking activity
- Alpha1-adrenoceptor blocking activities of bevantolol hydrochloride(NC-1400) and labetalol in rat isolated thoracic aorta - Do they distinguish between subtypes?
- Bevantolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris
- Quantitative analysis of β-adrenergic blocking agents by NMR spectroscopy
- Chiral purity test of bevantolol by capillary electrophoresis and high performance liquid chromatography
- Determination of bevantolol enantiomers in human plasma by coupled achiral-chiral high performance-liquid chromatography
考研文獻
TCIMail
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。